Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
Adenovirus gene therapy for intraperitoneal (IP) cancer is limited in clinical trials by inefficient tumor cell transduction and development of peritoneal adhesions. We have shown previously that normal virus tropism can be ablated by physically shielding the virus surface with reactive hydrophilic...
Үндсэн зохиолчид: | Morrison, J, Briggs, S, Green, N, Fisher, K, Subr, V, Ulbrich, K, Kehoe, S, Seymour, L |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2008
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
-н: Morrison, J, зэрэг
Хэвлэсэн: (2009) -
Retargeting adenovirus gene therapy via the epidermal growth factor receptor
-н: Morrison, J, зэрэг
Хэвлэсэн: (2006) -
Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
-н: Green, N, зэрэг
Хэвлэсэн: (2008) -
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
-н: Fisher, K, зэрэг
Хэвлэсэн: (2001) -
E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells.
-н: Bachtarzi, H, зэрэг
Хэвлэсэн: (2011)